About this event

BIO International Convention (BIO 2027) — Deep-Dive Buyer & Attendee Research Brief

Event Snapshot (Official Info from the Event Website)

• Event name: BIO International Convention
• Dates: June 7-10, 2027
• City/Country: Philadelphia, USA
• Venue name: Not specified in the provided official text (we leave this blank to avoid adding unverified facts).
• Event positioning (as stated): 4 days of programming, networking, and BIO Partnering™

How We Approach This Event (What This Research Is For)

We build an event intelligence view that helps us identify the highest-probability buyer segments that attend BIO International Convention based on the structure of the conference: (1) the attendee ecosystem (biotech/pharma/health innovation, investors, academia, service providers), (2) the dealmaking engine (BIO Partnering™), (3) the recurring focus areas (dealmaking, drug review policy, raising capital, cross-border expansion, patient relationships, scientific progress, AI implementation, biomanufacturing, and academia), and (4) the exhibitor/sponsor participation that typically concentrates budget owners and solution evaluators in defined tracks. Where the provided official text does not include a specific data point (for example, exact venue address or estimated attendance), we intentionally keep the value empty rather than guessing.

1) Who Attends (BUYERS / ATTENDEES)

BIO International Convention is best understood as a global biotech ecosystem summit with a strong “connection-to-commercialization” model. From the official website structure, the conference is centered on dealmaking and partnering, supported by policy, capital formation, cross-border expansion, and scientific/operational progress tracks. That means attendee composition typically includes both “direct decision-makers” and “influencers who shape vendor evaluation and partnering outcomes.”

Main attendee groups we expect (buyers / attendees)

• Biopharmaceutical and biotech leadership: executives and functional leaders tied to business development, licensing, pipeline strategy, partnering, and alliance execution.
• Deal and partnering professionals: teams directly involved in BIO Partnering™ matchmaking and internal decision routing after meetings.
• Investors and capital-seeking stakeholders: investors, venture teams, and capital-formation representatives aligned to “Raising Capital” and “Dealmaking” tracks.
• Scientific, clinical, and technical leadership: leaders aligned to “Scientific Progress,” “AI Implementation,” and “Biomanufacturing” themes.
• Policy and regulatory stakeholders: contributors and teams connected to “Drug Review Policy” and patient-related strategy.
• Academia and research ecosystem: academic representatives engaged in “Academia” focus areas and research collaboration pathways.
• Service providers and ecosystem vendors: companies spanning enabling technologies, biotech services, and operational support that benefit from introductions and partnership discussions during the partnering program.

Who are the “highest-fit buyer” profiles

• Business Development / Licensing leaders (for partnering outcomes and commercial collaboration)
• Alliance management teams (for partner execution and relationship continuity)
• Corporate development / strategy teams (for portfolio expansion and pipeline-adjacent deals)
• Investors and venture partners (for sourcing and evaluating new opportunities)
• Biomanufacturing and operational transformation leaders (for scaling capabilities and technology adoption)
• AI / data strategy leaders in biotech (for AI adoption planning and vendor shortlisting)
• Regulatory affairs and policy-aligned leaders (for environment shaping and strategic compliance roadmaps)
• Academia leadership (for collaboration formation and translational pathways)

2) Where the show is happening + attendee geographic origin

The official text confirms the event is in Philadelphia, USA for June 7-10, 2027. However, the provided excerpt does not name the specific venue facility. Therefore, we can reliably state the city/country, while we keep the venue field blank.

Geographic origin of attendees (what we can and cannot assert from the provided text)

The official page emphasizes “peers from across the global biotech ecosystem” in its description, indicating international relevance. Since the provided excerpt does not supply a percentage split (local vs national vs global), we treat geographic origin qualitatively:

• Local presence: meaningful due to a major US biotech and healthcare travel footprint (we cannot quantify locally from the provided excerpt).
• National presence: strong because BIO attracts US-based biopharma/biotech and ecosystem stakeholders (no numerical split provided).
• International presence: strongly indicated by “global biotech ecosystem” language (no numerical split provided).

Best geographic targeting we would recommend (based on typical BIO-style ecosystem behavior)

• Primary: United States-based biotech/pharma, investors, academic institutions, and major service providers.
• Secondary: North America and Europe biotech and innovation hubs (deal-driven partnering culture).
• Additional: cross-border innovation and expansion stakeholders aligned to “Cross-Border Expansion.”

3) Audience Reach (Local / National / Global)

Based on the official positioning—“peers from across the global biotech ecosystem”—BIO International Convention should be treated as a global reach event with an anchored US-centric core audience. Because the provided excerpt does not include reach metrics or attendance totals, we keep reach classification qualitative rather than numeric.

4) Sample buyer company names (BUYERS ONLY) + Websites

The table below includes representative buyer-side account types that align to BIO’s content pillars (dealmaking, raising capital, biomanufacturing, AI implementation, academia, and cross-border expansion). We recommend validating final buyer fit against the client’s product requirements before outreach list building. (Note: company names and website domains are provided for convenience; we do not infer confirmed attendance participation from the provided excerpt.)

Priority	Company	Website	Best Title to Target	Why This is a Good Buyer Fit
1	Amgen	https://www.amgen.com	Vice President, Business Development / Corporate Development; Head of Strategic Partnerships	Strong alignment with BIO Partnering™ and dealmaking; biotech pipeline and alliance execution needs partner-rich environments.
2	Genentech	https://www.gene.com	Senior Director, Business Development; Alliance Management Lead	Fit for partnership and commercialization discussions across scientific progress and cross-border collaboration themes.
3	Boehringer Ingelheim	https://www.boehringer-ingelheim.com	Director, Strategic Alliances; Head of BD Partnerships	Biopharma alliance strategy typically benefits from partnering formats and ecosystem networking.
4	ELI LILLY	https://www.lilly.com	Vice President, Business Development; Director, Partnering	Dealmaking and pipeline expansion teams use conferences to source partnerships and evaluate innovations.
5	Novo Nordisk	https://www.novonordisk.com	Head of External Innovation / Partnerships; Strategic Alliances Manager	External innovation and partnership sourcing maps well to BIO’s partnering and scientific progress agendas.
6	Sanofi	https://www.sanofi.com	Director, Corporate Development; Head of Strategic Partnerships	Cross-border expansion and partnering-driven growth aligns with BIO Partnering™ culture.
7	Moderna	https://www.modernatx.com	Director, Business Development; Strategic Partnerships Lead	Biotech collaboration needs are strongly aligned with dealmaking and translational research ecosystems.
8	Regeneron Pharmaceuticals	https://www.regeneron.com	Vice President, Business Development; Partnerships Director	Alliance and partnering professionals benefit from high-density meetings and solution evaluation opportunities.
9	Novartis	https://www.novartis.com	Head, External Innovation; Director, Strategic Partnerships	External innovation and partnership creation align with major event programming and BIO Partnering™ structure.
10	Roche	https://www.roche.com	Director, Alliance Management; Business Development Lead	Alliance management leaders typically look for partner fits across science, execution, and operational scaling.
11	Thermo Fisher Scientific	https://www.thermofisher.com	Global BD Director; Life Sciences Partnerships Leader	As an enabling services/technology ecosystem company, it aligns with partner-rich introductions during major biotech conferences.
12	Danaher	https://www.danaher.com	Director, Life Sciences Strategy; Partnerships & BD Lead	Enabling technology adoption and ecosystem collaboration align with “Biomanufacturing” and “AI Implementation.”
13	IQVIA	https://www.iqvia.com	VP, Business Development; Strategic Solutions Director	Service and analytics providers fit strong demand in policy, patient relationships, and operational strategy.
14	Charles River Laboratories	https://www.criver.com	Director, Strategic Partnerships; Business Development Manager	Research services ecosystem alignment supports meeting cycles focused on scientific progress and partnering.
15	Lonza	https://www.lonza.com	VP, Biomanufacturing Partnerships; Director, CDMO Business Development	Direct alignment with “Biomanufacturing” and scaling conversations in global biotech ecosystems.
16	Contract Pharma / CDMO Buyer-side (example)			CDMO Business Development Director; Strategic Sourcing Lead	Used as a template buyer profile type; we would populate specific company names after we receive the client website requirements.
17	Healthcare AI Startup/Platform Buyer-side (example)			Head of AI Strategy; Director, Digital Transformation	Template buyer profile for “AI Implementation” track alignment; we would select specific accounts using client product fit.
18	Biotech Venture Fund Buyer-side (example)			Partner, Venture Capital; Investment Director (Biotech)	Template for “Raising Capital” and investing logic; we would select precise funds/partners after we get client objectives.
19	Academic Research University / Institute Buyer-side (example)			Director, Technology Transfer; VP Research Partnerships	Template for “Academia” collaboration needs; we would identify specific institutions based on your product category.
20	Biopharma Policy/Market Access Buyer-side (example)			Head of Policy; Director of Regulatory Strategy	Template for “Drug Review Policy” and patient relationship agenda; we tailor the exact buyer list to your client requirements.

Top 5 buyer-side samples to start with (high-level): Amgen, Genentech, Boehringer Ingelheim, ELI LILLY, Novo Nordisk. These represent large-cap biotech/pharma buyer segments that strongly map to dealmaking, partnering, scientific progress, and external innovation needs.

5) Job profiles, industries & event type

Best job profiles to target (buyer titles we recommend)

• Vice President / Director, Business Development
• Director, Strategic Partnerships / Alliance Management
• Corporate Development Lead / Head of Corporate Development
• External Innovation Leader / Open Innovation Director
• Investment Director / Partner (Biotech focused)
• Head of Biomanufacturing / Bioprocess Operations leader
• Director, Digital Transformation / AI Strategy (Biotech)
• Regulatory Strategy Director / Drug Review Policy-adjacent leadership
• Academia collaboration leadership (Technology Transfer / Research Partnerships)
• Program leadership aligned to partnering execution (Partnering Ops / Meeting Strategy)

Industry & event type mapping (what BIO is, functionally)

Event type: Biotech/pharma industry conference with a strong dealmaking backbone via BIO Partnering™, plus technical/scientific programming and capital/policy tracks.
Primary industries represented: biopharmaceuticals, biotech innovation, life sciences services, enabling technologies, investors/venture, and academic research ecosystems.

6) Estimated attendance (expected total footfall)

Estimated attendance: Not provided in the provided official excerpt. We keep this field blank unless we receive additional official documentation or we can source a reliable figure from the full “Event Info” sections (outside the excerpt provided).

7) Key focus areas & buyer engagement

The official text lists explicit focus areas used in BIO programming. Those focus areas are the best “buyer engagement map” because they indicate where decision-making attention concentrates.

Key focus areas (from the event website)

• Dealmaking
• Drug Review Policy
• Raising Capital
• Cross-Border Expansion
• Patient Relationships
• Scientific Progress
• AI Implementation
• Biomanufacturing
• Academia

Buyer engagement model we see in this event format

• Partnering-driven meetings: BIO Partnering™ is designed to convert networking into scheduled conversations and partnership pipeline discussions.
• Track-based attention clusters: attendees align their schedules around the focus areas that match their responsibilities (BD, investing, policy, manufacturing, AI, academia).
• Exhibition and ecosystem discovery: exhibition presence and pavilion-style areas typically concentrate solution evaluators and vendor decision-makers.

Engagement angles we recommend for buyer outreach messaging

• “Dealmaking alignment” angle: position solutions as improving partnership evaluation, collaboration workflows, or alliance execution efficiency.
• “Capital and investor” angle: emphasize deal readiness, diligence acceleration, and measurable pipeline outcomes.
• “Biomanufacturing” angle: frame value around scaling, process robustness, and operational transformation.
• “AI implementation” angle: emphasize responsible adoption, integration into biotech workflows, and outcomes in scientific/operational decision-making.
• “Cross-border expansion” angle: emphasize compliance, localization, and global partner coordination benefits.

8) Client-product fit: We need your client website to identify best buyers

To determine the best buyer targets for BIO International Convention specifically for your use case, we need your client website URL. We will review your client’s positioning and then map it to BIO’s focus areas, and finally recommend the highest-probability buyer segments and corresponding job profiles to prioritize.

What we will do once you share the client website

• Extract the client’s product category (e.g., biomanufacturing-related, AI/analytics, research tools, regulatory/policy support, partnering enablement, capital/investor workflow tooling).
• Map the product to BIO focus areas (Dealmaking, Raising Capital, AI Implementation, Biomanufacturing, Drug Review Policy, etc.).
• Select the most relevant buyer industries from the event ecosystem using the industry list you provided.
• Choose the exact “Best Title to Target” set (BD/Corporate Development vs Biomanufacturing Ops vs AI Strategy vs Regulatory Strategy vs Investor leadership).
• Produce a refined list of best-fit buyer company samples (20+ buyer-quality accounts) with websites and targeting logic.

Your required input (please send)

• Client website: paste the URL
• What you want to achieve: list building for outreach, partnership selling, or sponsorship lead targeting (if applicable)
• Any constraints: geography, company size, job level, or specific sub-verticals

Once you share the client website, we will not provide generic BIO buyer lists; we will align the targets to your client’s actual requirement so the resulting buyer set matches your conversion goals.

9) Industry suggestions using your provided industry list

Based on BIO’s core themes (biotech, life sciences collaboration, biomanufacturing, AI in scientific/operational settings, and dealmaking), the most relevant industries from your provided list typically include:

Recommended industries to use for buyer filtering

• Pharmaceuticals
• Biotechnology
• Medical Devices
• Health, Wellness & Fitness (only where the client product intersects clinical/consumer health)
• Research
• Medical Practice (only where appropriate to your client’s category)
• Professional Training & Coaching (only if your client sells biotech workforce training or compliance training)
• Computer Software (if your client’s product is software/AI platform for biotech use cases)
• Computer & Network Security (only if your client is cybersecurity for health/life sciences data)
• Market Research (if your client provides analytics/market intelligence)
• Venture Capital & Private Equity (for investor buyer segments)
• Staffing & Recruiting (only if your client is talent services for biotech roles)
• Logistics & Supply Chain (if your client supports cold-chain or supply chain operations relevant to biotech manufacturing)
• Renewables & Environment (only if sustainability/green biotech manufacturing is directly relevant)
• Hospitality (generally not a BIO buyer fit unless your client is in event hospitality tooling; we do not prioritize this)

Final Recommendation (How We Position This Event for Buyer Targeting)

BIO International Convention is a high-value, dealmaking-centric biotech ecosystem event where buyer intent concentrates around partnering, investment, policy, scientific progress, AI adoption, and biomanufacturing scaling. If your client product aligns to any of these focus areas, this event is typically a strong match for building high-quality buyer targets with clearly mapped job-title steering.

Next step: share your client website URL, and we will return a refined, buyer-only prioritized table (20 or more accounts) mapped to BIO focus areas and the exact best-fit titles for your client’s requirement. We will also finalize the specific industry filters from your list to ensure your targeting stays precise.